1. Home
  2. HLLY vs ALT Comparison

HLLY vs ALT Comparison

Compare HLLY & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HLLY
  • ALT
  • Stock Information
  • Founded
  • HLLY 1903
  • ALT 1997
  • Country
  • HLLY United States
  • ALT United States
  • Employees
  • HLLY N/A
  • ALT N/A
  • Industry
  • HLLY Auto Parts:O.E.M.
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • HLLY Consumer Discretionary
  • ALT Health Care
  • Exchange
  • HLLY Nasdaq
  • ALT Nasdaq
  • Market Cap
  • HLLY 437.4M
  • ALT 292.0M
  • IPO Year
  • HLLY N/A
  • ALT N/A
  • Fundamental
  • Price
  • HLLY $4.07
  • ALT $3.83
  • Analyst Decision
  • HLLY Strong Buy
  • ALT Strong Buy
  • Analyst Count
  • HLLY 6
  • ALT 6
  • Target Price
  • HLLY $5.13
  • ALT $17.40
  • AVG Volume (30 Days)
  • HLLY 871.4K
  • ALT 3.0M
  • Earning Date
  • HLLY 08-06-2025
  • ALT 08-12-2025
  • Dividend Yield
  • HLLY N/A
  • ALT N/A
  • EPS Growth
  • HLLY N/A
  • ALT N/A
  • EPS
  • HLLY N/A
  • ALT N/A
  • Revenue
  • HLLY $593,797,000.00
  • ALT $20,000.00
  • Revenue This Year
  • HLLY $0.19
  • ALT N/A
  • Revenue Next Year
  • HLLY $5.09
  • ALT $761,880.20
  • P/E Ratio
  • HLLY N/A
  • ALT N/A
  • Revenue Growth
  • HLLY N/A
  • ALT N/A
  • 52 Week Low
  • HLLY $1.60
  • ALT $2.90
  • 52 Week High
  • HLLY $4.10
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • HLLY 79.82
  • ALT 51.79
  • Support Level
  • HLLY $3.58
  • ALT $3.35
  • Resistance Level
  • HLLY $3.91
  • ALT $3.66
  • Average True Range (ATR)
  • HLLY 0.16
  • ALT 0.19
  • MACD
  • HLLY 0.03
  • ALT 0.07
  • Stochastic Oscillator
  • HLLY 96.32
  • ALT 86.18

About HLLY Holley Inc.

Holley Inc is a designer, marketer, and manufacturer of high-performance automotive aftermarket products, featuring a portfolio of iconic brands serving the car and truck industry. It offers a diversified line of performance automotive products including fuel injection systems, tuners, exhaust products, carburetors, safety equipment and various other performance automotive products. The Company's products are designed to enhance street, off-road, recreational and competitive vehicle performance through increased horsepower, torque and drivability. The company's brands include Holley, APR, MSD and Flowmaster, among others. It derives revenue from the U.S. and Italy, of which prime revenue is derived from the U.S.

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: